Differentiation of mononuclear precursors into osteoclasts on the surface of Si-substituted hydroxyapatite

Journal of Biomedical Materials Research - Part A

Volumn 78, Issue 4, 2006, Pages 709-720

  Botelho, C M ^a,b   Brooks, R A ^c   Spence, G ^c   McFarlane, I ^c   Lopes, M A ^a,b   Best, S M ^d   Santos, J D ^a,b   Rushton, N ^c   Bonfield, W ^d  

^a INEB INSTITUTO DE ENGENHARIA BIOMÉDICA   (Portugal)

^b UNIVERSITY OF PORTO   (Portugal)

^c ADDENBROOKE S HOSPITAL   (United Kingdom)

^d UNIVERSITY OF CAMBRIDGE   (United Kingdom)

Author keywords

Differentiation; Monocytes CD14 positive; Osteoclasts; Peripheral blood mononuclear cells; Silicon substituted hydroxyapatite

Indexed keywords

BIOMARKERS; CELLS; SORPTION; SUBSTITUTION REACTIONS; SUBSTRATES; SYNTHESIS (CHEMICAL);

DIFFERENTIATION; MONOCYTES CD14 POSITIVE; OSTEOCLASTS; PERIPHERAL BLOOD MONONUCLEAR CELLS; SILICON-SUBSTITUTED HYDROXYAPATITE;

HYDROXYAPATITE;

ACID PHOSPHATASE TARTRATE RESISTANT ISOENZYME; ACTIN; CALCIUM; CD14 ANTIGEN; HYDROXYAPATITE; PHOSPHATE; SILICON; VITRONECTIN RECEPTOR;

ARTICLE; CELL DIFFERENTIATION; CONTROLLED STUDY; HUMAN; HUMAN CELL; MONOCYTE; OSTEOCLAST; OSTEOLYSIS; PERIPHERAL BLOOD MONONUCLEAR CELL; SURFACE PROPERTY;

ANTIGENS, CD14; CELL DIFFERENTIATION; DURAPATITE; MICROSCOPY, FLUORESCENCE; MONOCYTES; OSTEOBLASTS; SILICON;

EID: 33748188416     PISSN: 00219304     EISSN: 15524965     Source Type: Journal    
DOI: 10.1002/jbm.a.30726     Document Type: Article

References (37)

1. Schilling A, Linhart W, Filke S, Gebauer M, Schinke T, Rueger J, Amling M. Resorbability of bone substitute biomaterials by human osteoclasts. Biomaterials 2004;25:3963-3972.
2. Miller P, Baram D, Bilezkian J, Greenspan S, Lindsay R, Riggs B, Watts N. Practical clinical application of biochemical markers of bone turnover: Consensus of an expert panel. J Clin Densitom 1999;2:323-342.
3. Flanagan A, Massey H, Wilson C, Vellodi A, Horton MA, Steward C. Macrophage colony-stimulating factor and receptor activator NF-κ B ligand fail to rescue osteoclast-poor human malignant infantile osteopetrosis in vitro. Bone 2002;30:85-90.
4. Boyle W, Simonet W, Lacey DL, Osteoclast differentiation and activation. Nature 2003;423:337-342.
5. Susa M, Luong-Nguyen NH, Cappellen D, Zamurovic N, Gamse R. Human primary osteoclasts in vitro generation and applications as a pharmacological and clinical assay. J Transl Med 2004;2:6.
6. Anderson D, Maraskovsky E, Bilingsley W, Dougal W, Tometsko M, Roux E, Teepe M, DuBose R, Cosman D, Gilbert L. A homologue of the TNF receptor and its ligand enhance T-cell growth and dendritic-cell function. Nature 1997;390:175-179.
7. Matsuzaki K, Udagawa N, Takahashi N, Yamaguchi K, Yasuda H, Shima N, Morinaga T, Yoshiaki T, Yabe Y, Higashio K, Suda T. Osteoclast differentiation factor (ODF) induces osteoclast-like cell formation in human peripheral blood mononuclear cell cultures. Biochem Biophys Res Commun 1998;246:199-204.
8. Quinn J, Elliot J, Gillespie M, Martin T. A combination of Osteoclast differentiation factor and macrophage-colony stimulating factor is sufficient for both human and mouse osteoclast formation in vitro. Endocrinology 1998;139:4424-4427.
9. Massey H, Flanagan A. Human osteoclasts derive from CD14-positive monocytes. Br J Haematol 1999;106:167-170.
10. 3 integrin "vitronectin receptor". Int J Biochem Cell Biol 1997;29:721-725.
11. Doi Y, Shibutani T, Moriwaki Y, Kajimoto T, Iwayama Y. Sintered carbonate apatites as bioresorbable bone substitutes. J Biomed Mater Res 1998;39:603-610.
12. Langstaff S, Sayer M, Smith T, Pugh S. Resorbable bioceramics based on stabilized calcium phosphates. Part II: Evaluation of biological response. Biomaterials 2001;22:135-150.
13. Patel N, Best SM, Gibson IR, Hing KA, Damien E, Revell PA. A comparative study on the in vivo behaviour of hydroxyapatite and silicon-substituted hydroxyapatite granules. J Mater Sci: Mater Med 2002;13:1199-1206.
14. Botelho CM, Brooks RA, Lopes MA, Santos JD, Best SM, Rushton N, Bonfield W. Biological and physical-chemical characterization of phase pure hydroxyapatite and silicon-substituted hydroxyapatite by different microscopy techniques. Key Eng Mater 2004;254-256:845-849.
15. Gibson IR, Hung J, Best SM, Bonfield W. Enhanced in vitro cell activity and surface apatite layer formation on novel silicon-substituted hydroxyapatites. In: Ohgushi H, Hastings GW, Yoshikawa T, editors. Bioceramics, Vol. 12. Nara, Japan: World Scientific Publishing; 1999. p 191-194.
16. Jha LJ, Best SM, Santos JD, Gibson IR, Bonfield W. Silicon-substituted apatites and process for the preparation thereof. Worldwide Pat PCT/GB97/02325, 1999.
17. Gibson I, Best SM, Bonfield W. Chemical characterization of silicon-substituted hydroxyapatite. J Biomed Mater Res 1999;44B:422-428.
18. Botelho CM, Lopes MA, Gibson IR, Best SM, Santos JD. Structural analysis of Si-substituted hydroxyapatite: Zeta potential and X-ray photoelectron spectroscopy (XPS). J Mater Sci: Mater Med 2002;13:1123-1127.
19. Winchester RJ, Ross G. Methods for enumerating lymphocyte populations. In: Rose NR, Friedman H, editors. Manual of Clinical Immunology. Washington, DC: American Society for Microbiology; 1976. p 64-76.
20. Burstone MS. Histochemical demonstration of acid phosphatases with naphthol AS-phosphate. J Natl Cancer Inst 1958;21:423-539.
21. Monchau F, Lefevre A, Descamps M, Belquin-Myrdyez A, Laffargue P, Hildebrand HF. In vitro studies of human and rat osteoclast activity on hydroxyapatite, β-tricalcium phosphate, calcium carbonate. Biomol Eng 2002;19:143-152.
22. Chambers TJ. The regulation of osteoclastic development and function. Ciba Foundation Symposium 1988;136:92-107.
23. LakkaKorpi P, Tuukkanen J, Hentunen J, Jarvelin K, Vaananen K. Organization of osteoclast microfilaments during the attachment to bone surface in vitro. J Bone Miner Res 1989;4:817-825.
24. Nesbitt S, Horton MA. Trafficking of matrix collagens through bone-resorbing osteoclasts. Science 1997;276:266-269.
25. Salo J, Lehenkari P. Removal of osteoclast bone resorption products by transcytosis. Science 1997;276:270-273.
26. Vaananen K, Horton MA. The osteoclast clear zone is a specialized cell extracellular matrix adhesion structure. J Cell Sci 1995;108:2729-2732.
27. Kong YY, Feige U, Sarosi I, Bolon B, Tafuri A, Morony S, Cappareli C, Li J, Elliot R, MaCabes S, Wong T, Campagnuolo G, Moran E, Bogoch ER, Van G, Nguyen LT, Lacey DL, Fish E, Boyle WJ. OPGL is a key regulator of osteoclastogenesis, lymphocyte development and lymph-node organogenesis. Nature 1999;402:304-309.
28. Wittrant Y, Thepleyre S, Couillaud S, Dunstan C, Heymann D, Rédini F. Relevance of an in vitro osteoclastogenesis system to study receptor activator of NF-κ B ligand and osteoprotegerin biological activities. Exp Cell Res 2004;93:292-301.
29. Heymann D. gp130 cytokine family and bone cells. Cytokine 2000;12:1455-1468.
30. Heymann D, Gouin F, Passuti N, Daculsi G. Cytokines, growth factors and osteoclasts. Cytokine 1998;10:155-168.
31. Burgess T, Qian Y, Kaufman S, Ring B, Van G, Capparelli C, et al. The ligand for osteoprotegerin (OPGL) directly activates mature osteoclasts. J Cell Biol 1999;145:527-538.
32. Teitelbaum S. Bone resorption by osteoclasts. Science 2000;289:1504-1508.
33. Udagawa N, Takahashi N, Jimi E, Matsuzaki K, Tsurukai T, Itoh K, Nakagawa N, Yasuda H, Goto M. Osteoblasts/stromal cells stimulate osteoclast activation through expression of osteoclast differentiation factor/RANKL but not macrophage colony-stimulating factor. Bone 1999;25:517-523.
34. Zhang YM, Cai YR, Monchau F, Lefevre A, Zhao YM, Hildebrand HF. Biodegradation of synthetic bioglass with different crystallinity in vitro. In: Seventh World Biomaterials Congress, Sydney, 2004. p 1904.
35. Gomi K, Lowenberg B, Shapiro G, Davies JE. Resorption of sintered synthetic hydroxyapatite by osteoclasts in vitro. Biomaterials 1993;2:91-96.
36. De Bruijin JD, Bovel YP, Davies JE, Van Blitterswijik CA. Osteoclastic resorption of calcium phosphate is potentiated in postosteogenic culture conditions. J Biomed Mater Res 1994;28:105-112.
37. Botelho CM, Brooks RA, Kawai T, Ogata S, Ohtsuki C, Best SM, Lopes MA, Santos JD, Rushton N, Bonfield W. In vitro analysis of protein adhesion to phase pure hydroxyapatite and silicon-substituted hydroxyapatite. Key Eng Mat 2005;284-286:461-464.